ArticlePediatric nephrology (Berlin, Germany)2006
Successful outcomes with rituximab therapy for refractory childhood systemic lupus erythematosus.
Article in Pediatric nephrology (Berlin, Germany), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.Annals of the rheumatic diseases · 2011Pooled it
- Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2016Article
- Safety and efficacy of rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece.Rheumatology international · 2013Article
- Current treatment strategies: collagen vascular diseases in children.Indian journal of dermatology · 2012Article
- Rituximab therapy for juvenile-onset systemic lupus erythematosus.Pediatric nephrology (Berlin, Germany) · 2008Article
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.Annals of the rheumatic diseases · 2007Review
- Targeted B-cell depletion therapy in childhood-onset systemic lupus erythematosus: progress to date.Paediatric drugs · 2007Review
- Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2006Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
16508774What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.